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ARTICLE
Bi-directional cell-pericellular matrix interactions
direct stem cell fate
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Modifiable hydrogels have revealed tremendous insight into how physical characteristics of
cells’ 3D environment drive stem cell lineage specification. However, in native tissues, cells
do not passively receive signals from their niche. Instead they actively probe and modify their
pericellular space to suit their needs, yet the dynamics of cells’ reciprocal interactions with
their pericellular environment when encapsulated within hydrogels remains relatively unex-
plored. Here, we show that human bone marrow stromal cells (hMSC) encapsulated within
hyaluronic acid-based hydrogels modify their surroundings by synthesizing, secreting and
arranging proteins pericellularly or by degrading the hydrogel. hMSC’s interactions with this
local environment have a role in regulating hMSC fate, with a secreted proteinaceous peri-
cellular matrix associated with adipogenesis, and degradation with osteogenesis. Our
observations suggest that hMSC participate in a bi-directional interplay between the prop-
erties of their 3D milieu and their own secreted pericellular matrix, and that this combination
of interactions drives fate.
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Regenerative therapies that combine stem cells with mate-rials offer tremendous clinical promise, yet, controllingdifferentiation and tissue formation remain a pressing
challenge. In addition to soluble factors, physical characteristics of
the extracellular milieu are known to direct lineage specification1,
however, how cell-extracellular matrix (ECM) interactions drive
this process in in vivo-like environments remains incompletely
understood. In 3D hydrogels2,3, a stem cell’s ability to probe
hydrogel stiffness4 and degrade its surroundings5 regulates fate.
However, such findings are complicated in hydrogels with time-
dependent properties that better mimic the native ECM6.
Hydrogels that stiffen or soften in a controlled manner7,8, that
undergo stress stiffening9, or are viscoelastic10–13 have revealed a
role for dynamic changes in hydrogel physical properties in
guiding stem cell fate.
However, cells do not passively respond to signals delivered to
them, whether they are static or dynamic. Instead, many cell types
actively modify their local environment by secreting a protei-
naceous ECM and degrading their surroundings to suit their
needs. This is apparent in the epidermis, where cell–ECM inter-
actions reciprocally regulate the stem cell niche14,15. Disrupting
this balance, as occurs in epidermolysis bullosa, a family of skin
blistering disorders in which cells fail to deposit type VII collagen,
demonstrates the importance of bi-directional interactions in
tissue maintenance. Reciprocal cell-ECM interactions have also
been described in the field of biomaterials, where cells quickly
“compatibilize” non-adhesive surfaces by secreting/assembling a
proteinaceous matrix which they actively probe16, even in the
absence of serum proteins17. The role of bi-directional interac-
tions in 3D hydrogels are less well studied, and while secreted
ECM has been hypothesized to influence cell response4,18,19, how
it directs encapsulated cells remains relatively unexplored.
Here, we show that when encapsulated within hyaluronic acid
(HA)-based hydrogels, hMSC quickly modify their surroundings
via protein secretion and/or matrix degradation. These cell-
mediated local modifications impact hMSC fate, with secretion of
a proteinaceous pericellular matrix driving adipogenesis and
degradation of the hydrogel matrix promoting osteogenesis. Our
findings suggest that hydrogel physical properties may not direct
fate in isolation, but rather impact how hMSC modulate their
pericellular surroundings, which in turn directs differentiation.
Results
Encapsulated hMSC form a proteinaceous pericellular matrix.
To study the role of cell-secreted ECM in regulating hMSC fate in
3D, we utilized hydrogels based on a well-described Michael
addition between thiol-modified HA (S-HA) and poly(ethylene
glycol) diacrylate (PEGDA) (Fig. 1a)20. S-HA-PEGDA hydrogels
form quickly under mild conditions, allowing cell encapsulation.
They also offer insight into the role of cell-secreted ECM in
directing fate, because like un-modified PEG, they provide no
sites for integrin-mediated interactions. However, unlike in PEG
where the lack of adhesive motifs can prompt anoikis21, HA
interactions with surface receptors, such as CD44 and
RHAMM22, allow for long-term cell viability23, limiting integrin-
mediated interactions to those with the cells’ own secreted ECM.
Moreover, like other modifiable hydrogels, S-HA-PEGDA’s
physical properties can be tuned over a wide range8.
By holding the concentration of S-HA constant and varying the
concentration of PEGDA (described as weight ratios, 1:relative
weight PEGDA), we formed hydrogels that ranged from being
primarily composed of S-HA to PEGDA-dominated hydrogels
(Supplementary Table 1). We then carried out standard
characterization techniques and found that S-HA-PEGDA
hydrogels undergo expected24 PEGDA concentration-dependent
swelling (Supplementary Fig. 1). Similarly, treatment with
hyaluronidase results in PEGDA concentration-dependent degra-
dation (Supplementary Fig. 2), confirming that HA remains
integral to the hydrogel network and that the thiol-modification
does not preclude enzymatic degradation. Atomic force micro-
scopy (AFM)-based indentation measurements 72 h after cross-
linking showed that Young’s modulus (E) increased with
increasing PEGDA concentration until the molar ratio of acrylate
exceeded that of thiols required for ideal cross-linking, after
which adding more PEGDA decreased stiffness25. Over time and
in line with enzyme-mediated degradation (in the presence of
serum) and inherent degradation via ester hydrolysis8, hydrogels
softened and differences in E among compositions were
attenuated (Supplementary Fig. 3). Although not explicitly
designed into the system, these time-dependent behaviors were
in line with those observed in biological systems which self-
modify over days to weeks26.
We then encapsulated hMSC in S-HA-PEGDA hydrogels and
observed that they remained viable, but exhibited limited
proliferation over 4 weeks (Supplementary Fig. 4), as previously
described9,27. Encapsulated hMSC also adopted round morphol-
ogies (Supplementary Fig. 5) regardless of PEGDA concentration,
in keeping with the lack of adhesive motifs within S-HA-PEGDA
hydrogels. Quantification by flow cytometry of free thiols on
hMSC’s surfaces28 after labeling with a maleimide-modified Alexa
Fluor showed no differences compared to N-ethylmaleimide-
treated controls (Supplementary Fig. 6), confirming that few if
any covalent bonds were possible between hMSC and hydrogels.
We then blocked cells’ interactions with HA using an anti-CD44
antibody and observed a quick (24 h) drop in viability compared
to treatment with isotype controls (Fig. 1b). This confirmed HA’s
role in promoting survival of encapsulated cells in the absence of
integrin-mediated interactions. Nevertheless, when we added
peptides containing an RGD sequence, which block many
integrin-mediated interactions, we observed a surprising similar
reduction in viability (Fig. 1c). Therefore, while hMSC-HA
interactions via CD44 had an expected role, integrin-mediated
interactions also appeared to have a quick, unexpected role in
maintaining viability, even though hydrogels had not been
modified with adhesive motifs.
To understand how integrin-mediated interactions could have
influenced viability, we next labeled proteins synthesized by
hMSC over the first 72 h after encapsulation using a non-
canonical amino acid tagging technique, which substitutes the
canonical amino acid methionine with a non-canonical analogue
that contains a bio-orthogonal functional group29. Using a simple
click chemistry to fluorescently identify the incorporated label,
this allowed us to image intracellular proteins as well as secreted
proteins retained in the hydrogel surrounding hMSC. Images of
labeled proteins showed that hMSC in 1:0.375 and 1:3 hydrogels
assembled an extensive proteinaceous pericellular matrix around
themselves, while in 1:0.75 hydrogels, the pericellular matrix
appeared to be more limited (Fig. 1d). Quantification of the mean
intensity of the signal of labeled proteins in radii measured from
the cell membrane showed that in 1:0.375 and 1:3 hydrogels,
secreted proteins were detectable more than 40 µm from the cell
surface, but in 1:0.75 hydrogels, we detected little to no signal
beyond ~5 µm. These observations show that while hMSC secrete
proteins under all conditions, hydrogel composition influences
secreted proteins’ density and distribution in the pericellular
space.
To better understand the composition of this secreted matrix,
we next performed a stable isotope labeling with amino acids in
cell culture (SILAC) experiment to identify proteins produced by
hMSC post-encapsulation. SILAC media contains heavy isotope
labeled arginine and lysine, which are metabolically incorporated
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Fig. 1 hMSC within S-HA-PEGDA hydrogels synthesize and secrete proteins pericellularly. a Reaction scheme for hydrogel formation. Thiol-modified
hyaluronic acid (S-HA) cross-links with poly(ethylene glycol) diacrylate (PEGDA) to form a hydrogel via a Michael addition. b Viability of hMSC
encapsulated in 1:0.75 hydrogels treated with an anti-CD44 (CD44+) antibody or an isotype control (CD44−) for 24 h and normalized to vehicle controls
(n≥ 3). c Viability of hMSC encapsulated in 1:0.75 hydrogels treated for 24 h with RGD sequence-containing peptides (RGD+) or scrambled peptides
(RGD−) and normalized to vehicle controls (n≥ 3). In b and c plots show means ± s.d. d Representative micrographs showing fluorescence labeling of the
methionine analogue L-homopropargylglycine (HPG, green) in hMSC-laden 1:0.375, 1:0.75, and 1:3 hydrogels after 72 h in culture. The cell membrane, as
determined by differential interference contrast (DIC) imaging, is outlined in white. Scale bar= 100 µm, inset= 10 µm. Plots show mean intensity of the
fluorescence signal (±s.e.m.) as a function of distance from the cell membrane in 1:0.375 (blue dashes), 1:0.75 (green dashes), and 1:3 (red dashes)
hydrogels and were generated from 40 profile plots collected from 30 cells per condition. e Fraction of SILAC heavy-labeled proteins in decellularized
1:0.375 (blue circles), 1:0.75 (green circles), and 1:3 (red circles) hydrogels cultured for 72 h. Scatterplots show two technical replicates (H/L count≥ 3) for
each hydrogel composition. Gene names for ECM proteins showing high levels (>40%) of SILAC incorporation are highlighted in each panel
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into newly synthesized proteins. We then decellularized hydrogels
and applied an “in-hydrogel digestion” method that allowed us to
use mass spectrometry to determine the fraction of more than
1100 proteins remaining in hydrogels that contained the heavy
label (Fig. 1e, Supplementary Fig. 7 and Supplementary Data 1).
ECM proteins including fibronectin, collagens and periostin,
among others, showed high levels (>40%) of incorporation within
all hydrogel compositions.
Taken together, these observations provide unequivocal
evidence that hMSC synthesize, secrete and assemble a proteinac-
eous pericellular matrix around themselves post-encapsulation.
They also show that secreted proteins have a role in maintaining
cell viability and suggest that when adhesive motifs are not
available in 3D culture, hMSC synthesize them.
Encapsulated hMSC modulate their pericellular stiffness. As
hMSC synthesized and secreted proteins after encapsulation, we
next asked what effect this had on hydrogel physical properties.
AFM is particularly insightful in this context because by adapting
the cantilever with a bead, we can probe E at the scale of a cell
within live cultures. In 1:0.375 hydrogels, the presence of
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encapsulated hMSC mediated a significant increase in E after
3 days in culture (Fig. 2a). Cell-mediated effects were also evident
in 1:3 hydrogels (Fig. 2c), where E increased by nearly an order of
magnitude. Increases in E were not associated with either
inherent or cell-mediated changes in bulk hydrogel dimensions
(Supplementary Fig. 8), but rather accompanied by bi-modal
distributions of E (Fig. 2, histograms). Unsupervised peak fitting
identified one value similar to that of acellular controls and
another that was stiffer. Treating cultures with Exo-1, an inhibitor
of vesicular trafficking between the ER and Golgi30, and thus a
protein secretion inhibitor, had no detectable effect on cellular
metabolism (Supplementary Fig. 9). However, in 1:0.375 and 1:3
hydrogels, Exo-1 abolished (1:0.375) or significantly altered (1:3,
Supplementary Table 2) the bi-modal distributions and effected a
significant decrease in E (Fig. 2a, c). Drawing on observations
from cartilage biomechanics, where differential stiffnesses have
been detected between the pericellular and bulk extracellular
space surrounding chondrocytes31, our observations suggest that
in 1:0.375/1:3 hydrogels, hMSC secreted proteins to form a
pericellular matrix that was stiffer than that of the bulk hydrogel.
In contrast to our observations in 1:0.375 and 1:3 hydrogels, in
1:0.75 hydrogels (Fig. 2b), the presence of hMSC mediated a
significant decrease in E, and a bi-modal distribution was not
evident. In 1:0.75 hydrogels, treatment with the hyaluronidase
inhibitor Vcpal32 (which blocks hyaluronidase-mediated degra-
dation of S-HA, Supplementary Fig. 9c) precipitated the
appearance of a bi-modal distribution and a significant increase
in E. These observations suggested that within 1:0.75 hydrogels,
hMSC modulated their local environment predominantly via
degradation.
Changes in E of cell-laden hydrogels have been reported, but
often with chemical induction that stimulates extensive ECM
formation and with higher cell densities18,23,33,34. Here, we used
basal medium and relatively low cell densities, which allowed us
to isolate how individual cells inherently modified their
environment. Taken together, our observations suggest that
within S-HA-PEGDA hydrogels, hMSC quickly modified their
local environment, by degradation (to soften stiffer hydrogels) or
secretion of proteins pericellularly (to locally stiffen softer
hydrogels).
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Fig. 3 hMSC’s modifications to their pericellular environment directs fate. a Ratio of expression of PPARγ to RUNX2 in hMSC encapsulated in hydrogels for
72 h and normalized to undifferentiated hMSC controls (mean+ s.d.). Ratios were significantly higher in 1:0.375 and 1:3 (*p < 0.05) compared to 1:0.75
hydrogels (n≥ 4). b Ratio of expression of PPARγ to RUNX2 in hMSC after treatment with RGD sequence-containing peptides (RGD+) for 72 h (mean+ s.
d.). Ratios were not significantly different in hydrogels of different compositions (n≥ 8), but for each composition, expression was significantly different
than RGD− controls (1:0.375 and 1:3, *p < 0.05; 1:0.75, ***p < 0.001). c Fraction of hMSC that stained positively for Oil Red O (ORO+) or alkaline
phosphatase (ALP+), as indicators of adipogenesis and osteogenesis, respectively, after 14 days in culture in a bi-potential osteogenic/adipogenic medium
(n= 3300–1200 cells). d Ratio of expression of PPARγ to RUNX2 in hMSC after treatment with 75 μM Exo-1 or f 100 μM Vcpal for 72 h (mean+ s.d.).
Fraction of hMSC that stained positively for ORO and ALP after treatment with either e 75 μM Exo-1 or g 100 μM Vcpal for 14 days (n= 3300–1200 cells).
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Cell-mediated pericellular modifications drive hMSC fate. We
next asked how cell-mediated changes in hydrogel properties
affected hMSC differentiation, initially in the absence of chemical
induction. Others have shown that HA promotes a bias towards
the chondrogenic lineage23,33. And, indeed, pericellular staining
for type II collagen and upregulation of chondrogenic genes SOX9
and COL2A1, were evident in all compositions (Supplementary
Fig. 10). However, examining markers for other fates yielded
hydrogel composition-dependent differences in lineage specifi-
cation. The ratio of expression of adipogenic and osteogenic
transcription factors PPARγ and RUNX2, respectively, was sig-
nificantly higher in hMSC encapsulated in 1:0.375 and 1:3
hydrogels compared to that in 1:0.75 hydrogels (Fig. 3a), sug-
gesting that the former favored adipogenesis and the latter
osteogenesis. This was supported by trends for upregulation of
BGLAP (osteocalcin) in 1:0.75, and upregulation of C/EBPα
(adipogenic transcription factor) in 1:0.375 and 1:3 hydrogels
(Supplementary Fig. 11), which we confirmed by immuno-
fluorescence staining (Supplementary Fig. 12). The addition of
RGD sequence-containing peptides abolished differences in
osteogenic/adipogenic gene expression (Fig. 3b and Supplemen-
tary Fig. 11), suggesting that integrin-mediated interactions with
hMSC’s own secreted pericellular matrix biased their tendency
towards different lineages. Longer-term culture in the presence of
bi-potential osteogenic/adipogenic medium35 prompted hMSC to
undergo terminal differentiation as determined by quantification
of staining for alkaline phosphatase (ALP) and Oil Red O (ORO,
Fig. 3c, Supplementary Fig. 13 and Supplementary Table 3).
These observations confirmed that 1:0.375 and 1:3 hydrogels
drove adipogenesis and 1:0.75 hydrogels prompted hMSC to
undergo osteogenesis.
To better understand the role of cell-mediated modifications to
the local pericellular environment in driving differentiation, we
next inhibited protein secretion with Exo-1. Exo-1 abrogated
adipogenesis in 1:0.375 and 1:3 hydrogels (Fig. 3d, e, Supple-
mentary Fig. 13, 14, and Supplementary Table 3) and was
observed concomitant with the loss of clear bi-modal distribu-
tions of E (Fig. 2a, c). These observations imply that formation of
a proteinaceous pericellular matrix was necessary for adipogen-
esis in 1:0.375 and 1:3 S-HA-PEGDA hydrogels. Exo-1, however,
did not affect the ratio of expression of PPARγ to RUNX2 in
1:0.75 hydrogels and only subtly affected the fraction of ALP
positive cells (Fig. 3d, e, Supplementary Fig. 13 and Supplemen-
tary Table 3), suggesting that protein secretion did not regulate
osteogenesis in the 1:0.75 composition. Inhibiting hyaluronidase
activity with Vcpal, on the other hand, abolished the upregulation
of osteogenesis in 1:0.75 hydrogels (Fig. 3f, g, Supplementary
Figs. 13, 14 and Supplementary Table 3) and coincided with the
emergence of a bimodal distribution of E (Fig. 2b). This finding
supports previous observations that degradation is a key mediator
of hMSC lineage specification5. Vcpal, however, also significantly
downregulated adipogenesis (Fig. 3f, g) in and softened 1:0.375
and 1:3 hydrogels (Fig. 2a, c), suggesting that hMSC may have to
degrade their pericellular milieu to secrete ECM, as has been
observed during native tissue remodelling36. And indeed, when
we applied the non-canonical amino acid tagging technique to
analyze the pericellular matrix that formed around hMSC after
treatment with Vcpal, we observed less pericellular staining
compared to controls (Supplementary Fig. 15).
To rule out a role of differential nutrient and/or growth factor
diffusion in differentiation, we carried out fluorescence recovery
after photobleaching, and failed to observe an effect of hydrogel
composition on the diffusion of model molecules (Supplementary
Fig. 16). Similarly, as HA fragments of different molecular
weights have been reported to influence human embryonic stem
cell self-renewal/differentiation37, we also treated hMSC with
fragments from degraded hydrogels, but observed no effects on
gene expression (Supplementary Fig. 17). Taken together, these
findings suggest a bias in differentiation whereby cell-mediated
formation of a proteinaceous pericellular matrix drives adipogen-
esis, and osteogenesis is driven by cell-mediated degradation of
the matrix, which softens the hydrogel.
Although hMSC could not form integrin-mediated interactions
with the initial S-HA-PEGDA hydrogels, our data suggest that it
was modified through a combination of degradative and secretive
mechanisms. Although conflicting reports exist on the necessity
of degradability in mechanotransduction-mediated hMSC differ-
entiation in 3D4,5,9, there is more consensus on the need for
adhesive ligands. In non-adhesive hydrogels, small molecule
inhibitors of cytoskeletal tension have no effect on hMSC
differentiation19,38, but when adhesive ligands are present,
blocking induces a fate switch5 or abolishes differentiation9.
When we treated cultures with the RhoA/ROCK inhibitor Y-
27632, we observed a trend for an overall decrease in expression
of genes indicative of both the osteogenic and adipogenic lineages,
although this was not significant in many cases (Fig. 4a and
Supplementary Fig. 18). This was in keeping with previous
reports of hMSC response in hydrogels that undergo controlled
stress-stiffening behaviour9. Our SILAC-based proteomic analysis
revealed that hMSC encapsulated in all hydrogel compositions
secreted numerous ECM proteins. Immunostaining for fibronec-
tin, which strongly incorporated the SILAC label, identified it
pericellularly, where it co-localized with punctate α5 integrin
(Fig. 4b). This suggests that integrin-mediated interactions could
have taken place and that differentiation here could have been
driven, at least in part, by actin-mediated cytoskeletal tension
mediated via the secreted pericellular matrix, despite cells’ round
morphologies (Fig. 4c). However, recent reports have also
suggested that microtubules may also have a role in
mechanotransduction-mediated differentiation in the absence of
cell spreading9 via the microtubule-associated protein
DCAMKL1, which antagonizes RUNX2 transcriptional activity39.
Treating cells with paclitaxel, an inhibitor of microtubule
depolymerization, eliminated composition-dependent differences
in gene expression, precluding upregulation of RUNX2
and BGLAP in 1:0.75 hydrogels and abolishing upregulation
of PPARγ and C/EBPα in 1:0.375 and 1:3 hydrogels (Fig. 4d
and Supplementary Fig. 18). As staining encapsulated hMSC for-
tubulin revealed a well-defined network (Fig. 4e), these
observations suggest that the microtubule network may
have a role in regulating gene expression under these
conditions.
Discussion
In summary, hMSC within S-HA-PEGDA hydrogels quickly
modify the composition and physical characteristics of their
pericellular space and interact with it to direct their fate. Here,
we found that pericellular matrix deposition drove adipogenesis
in hydrogels that were inefficiently cross-linked (1:0.375/1:3),
but matrix degradation promoted osteogenesis when hydrogel
cross-linking was more efficient (1:0.75). Cross-linking effi-
ciency will impact numerous hydrogel properties, including
mesh size, stiffness, and the susceptibility of the hydrogel to
enzymatic degradation and matrix deposition. We were not
able to identify which specific property mediated our observa-
tions here, but all remain possibilities. Our proteomic analysis
identified proteins secreted by hMSC that were retained in the
hydrogels, but did not identify which or if specific proteins
directed cellular responses. As many proteins often act in
concert in vivo to direct cell behaviours, it is likely that
numerous proteins were similarly involved here. In our
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experiments, we kept the concentration of HA constant in all
hydrogel compositions, but we cannot rule out its own biolo-
gical influence, as HA can modulate cellular mechan-
otransduction40. Moreover, whereas others have linked
osteogenesis to cell spreading and traction5, our observations
suggest that cell-mediated degradation in the absence of cell
spreading may be sufficient, confirming previous reports4,19,41.
Our observations of cell-mediated modifications of pericellular
matrix may explain conflicting observations in different
hydrogel systems, despite similar stiffnesses and ligand pre-
sentation, as hydrogel properties per se may not always directly
regulate hMSC, but rather impact the formation of pericellular
matrix, which in turn influences fate. Indeed, our data suggest
that hMSC participate in a reciprocal interplay between the 3D
milieu they are presented with and their own secreted pericel-
lular matrix and this combination of interactions directs fate.
Fibronectin α5 integrin DAPI
Actin DAPI
Tubulin DAPI
10,000
*
a
c
b
d
e
Fo
ld
 c
ha
ng
e 
in
 g
en
e 
ex
pr
es
sio
n
1000
100
10
1
0.1
0.01
Fo
ld
 c
ha
ng
e 
in
 g
en
e 
ex
pr
es
sio
n
***
*
***
*
Fo
ld
 c
ha
ng
e 
in
 g
en
e 
ex
pr
es
sio
n
Fo
ld
 c
ha
ng
e 
in
 g
en
e 
ex
pr
es
sio
n
Y– Y+
1:0.375 1:0.75
C/EBP
PPAR 
PPAR 
1:3
Y– Y+ Y– Y+
1:0.375 1:0.75 1:3
Y– Y+
1:0.375 1:0.75 1:3
Y– Y+ Y– Y+
C/EBP
Fo
ld
 c
ha
ng
e 
in
 g
en
e 
ex
pr
es
sio
n
10,000
1000
100
10
1
0.1
0.01
10,000
Fo
ld
 c
ha
ng
e 
in
 g
en
e 
ex
pr
es
sio
n
1000
100
10
1
0.1
0.01
RUNX2
Y– Y+
1:0.375 1:0.75
BGLAP
1:3
Y– Y+ Y– Y+
Y– Y+
1:0.375 1:0.75 1:3
Y– Y+ Y– Y+
PTX– PTX+ PTX– PTX+ PTX– PTX+
1:0.375 1:0.75 1:3
PTX– PTX+ PTX– PTX+ PTX– PTX+
1:0.375 1:0.75 1:3
10,000
1000
100
10
1
0.1
0.01
10,000
1000
100
10
1
0.1
0.01
10,000
1000
100
10
1
0.1
0.01
***
**10,000
Fo
ld
 c
ha
ng
e 
in
 g
en
e 
ex
pr
es
sio
n
1000
100
10
1
0.1
0.01
Fo
ld
 c
ha
ng
e 
in
 g
en
e 
ex
pr
es
sio
n
RUNX2
BGLAP
1:0.375 1:0.75 1:3
PTX– PTX+ PTX– PTX+ PTX– PTX+
1:0.375 1:0.75 1:3
PTX– PTX+ PTX– PTX+ PTX– PTX+
10,000
1000
100
10
1
0.1
0.01
***
NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-06183-4 ARTICLE
NATURE COMMUNICATIONS |          (2018) 9:4049 | DOI: 10.1038/s41467-018-06183-4 | www.nature.com/naturecommunications 7
Methods
Hydrogel preparation. Sodium hyaluronate (Lifecore Biomedical, USA, mean
molecular weight 111 kDa) was thiolated as previously described20,24,42,43 to
achieve a polymer degree of substitution between 30 and 40% of the D-glucuronic
acid units. The degree of substitution was quantified by proton nuclear magnetic
resonance (1H-NMR) spectroscopy (Supplementary Fig. 19) as previously descri-
bed20, and confirmed using the Ellman procedure44. The resulting product was
sterilized with 25 kGy gamma irradiation using a Gammacell 1000 (Best Thera-
tronics Ltd., UK). As CD44 requires a hexasacchride to allow for binding6 and as
higher molecular weight hyaluronic acid (HA) binds to more CD44 receptors45, we
hypothesized that working in the molecular weight range of 100–150 kDa HA
would allow cells access to multiple binding sites while still tolerating a reasonable
degree of chemical modification46. And indeed, while others who have utilized
more extensively modified HA report limited cell interactions25, blocking (Fig. 1b)
and degradation (Supplementary Fig. 2) studies confirmed hMSC could interact
with, and hyaluronidase could degrade HA with this degree of chemical
modification.
Cylindrical hydrogels (100 μL volume) were prepared in polytetrafluoroethylene
molds (6 mm diameter) by combining a constant amount of S-HA (8 mgmL−1)
and varying the concentration of PEGDA (ESI-BIO, USA, 3400Da, 1.5–48mgmL−1),
as outlined in Supplementary Table 1. S-HA and PEGDA were both solubilized in
phosphate buffered saline (PBS, without calcium and magnesium). The solution
was then pipetted into molds and allowed to crosslink at 37 °C in a humidified
atmosphere of 5% CO2/95% air for 2 h prior to the addition of basal culture
medium (alpha modified Eagle’s medium, αMEM, no nucleosides) with 10% Fetal
Bovine Serum (FBS, Gibco, UK) and 1% (v/v) antibiotic-antimycotic solution
(Sigma) and removal of the molds.
Mechanical characterization of hydrogels by AFM. Spherical glass beads (dia-
meter 55–75 μm; Polysciences, Inc, DE) were mounted onto tipless triangular
silicon nitride cantilevers (spring constant (K) ≈ 0.06–0.24 Nm−1; Bruker AXS
SAS, FR) using UV-cross-linked Loctite super glue (Hemel Hempstead, UK). The
diameter of each microsphere was then measured on a Leica MZ FL III fluores-
cence stereomicroscope with a Leica DFC300 FX digital colour camera using Leica
FireCam software (Leica Microsystems, CH) using a standard scale. Prior to any
sample measurements, the deflection sensitivity of the AFM photodiode was
calibrated by performing a single force-distance curve on a glass slide following
standard protocols. Cantilevers were then calibrated using the thermal method47 in
air and repeated up to three times to confirm the value of the spring constant.
Hydrogels ~3 mm in thickness (to minimize the stiffness contribution from the
underlying support48) were immobilized in 60 mm diameter tissue culture dishes
(TPP, CH) by gluing coverslips to the plate at the edges of the hydrogel. In this
setup, the coverslips act as clamps on the edge of the hydrogels, avoiding the need
of gluing the hydrogel to the petridish. The mounting of the hydrogels was suffi-
cient to hold them in place without exerting compressive load in the area probed by
AFM. The hydrogels were kept hydrated (PBS) at room temperature (RT) at all
times during the preparation, mounting, and force-distance measurements to
ensure that their physical properties were not altered. Unfixed or otherwise
manipulated hydrogels, with or without live cells, were taken directly from the cell
culture incubator, immersed in ~4.5 mL of PBS at RT (measurements both in the
presence and absence of live cells were completed within 1 h with a resting time of
10 min after mounting for thermal equilibrium stabilization) and measurements
were carried out on a JPK Nanowizard I AFM with J Unicam using JPK SPM
software 2.3 01/2006 (JPK Instruments AG, DE). Force measurements were made
at randomly selected locations across the hydrogel surface (at least 10 locations and
10 force curves per location on at least two technical replicate hydrogels per bio-
logical replicate). Randomly selected areas were always at least 100 µm from each
other. The total number of force curves that were used for each analysis are given in
Supplementary Table 2. Indentations were carried out with a relative setpoint force
of 30 nN and a loading rate of 30 μm s−1. E was determined with JPK SPM
software using the Oliver–Pharr model49 for a spherical tip, as previously descri-
bed48. This analysis is based on an elastic–plastic contact mechanical model. As for
other hydrated biological samples, we assumed that volume was conserved and
assigned a Poisson’s ratio of 0.5.
Histograms were plotted with identical bin sizes for each hydrogel composition
and E was then determined by fitting a Gaussian distribution to the histogram
(only when tolerance criteria were 100% satisfied in OriginPro 8 SR0 software) and
identifying the centre of the peak. Standard error was determined as the half width
of the Gaussian peak, as previously described50.
hMSC isolation, culture, and characterization. Human samples used in this
research project were obtained from the Imperial College Healthcare Tissue Bank
(ICHTB, HTA license 12275). ICHTB is supported by the National Institute for
Health Research (NIHR) Biomedical Research Centre based at Imperial College
Healthcare NHS Trust and Imperial College London. ICHTB is approved by the
UK National Research Ethics Service to release human material for research
(12/WA/0196), and the samples for this project were issued from sub-collection
R16052. Clinical-grade, bone marrow-derived hMSC were generated from bone
marrow (BM) aspirates collected from the iliac crest of healthy paediatric donors
with informed consent. BM aspirate was collected in 10 mL tubes and cells were
plated the same day in CellSTACK® (Corning, UK) culture chambers at 10–25 ×
106 per 636 cm2 after establishing the total number of nucleated cells on a Sysmex
SE full blood count analyzer. Cells were cultured in αMEM supplemented with 5%
human platelet lysate (Stemulate, Cook Medical, USA) and cultured under stan-
dard conditions. When cell confluence of 90–100% was achieved (10–14 days), cells
were detached with recombinant trypsin (Roche, DE) and reseeded at 5000 cells
per cm2. Cells were then routinely expanded in αMEM supplemented with 10% (v/
v) FBS (using 0.05% Trypsin-EDTA, Thermo Fisher Scientific) and used prior to
passage 7. Cells were immunophenotyped with a panel of labeled mouse anti-
human antibodies and found to express markers CD90, CD105, CD73, and not
express haematopoietic markers CD34 and CD4551. Immunophenotyping was
performed at passages 0, 1, 4, and 7. hMSC were tested and devoid of mycoplasma
contamination before being used in experiments.
hMSC encapsulation in hydrogels. To encapsulate cells, hMSC were trysinized at
~80% confluency and pelleted. Cells were resuspended in αMEM to constitute 8%
of total final hydrogel volume, mixed with hydrogel components and pipetted into
molds placed within 48-well suspension plates. Hydrogels were allowed to cross-
link under standard culture conditions for 2 h before molds were removed and
1 mL of basal culture medium supplemented with 1% (v/v) antibiotic-antimycotic
solution was added. Media were exchanged every 3–4 days.
SILAC media, amino acids, and dialysed serum for proteomics. SILAC αMEM,
no nucleosides, no lipoic acid was made up in-house under sterile conditions.
Heavy SILAC medium was prepared with 0.1 mg mL−1 heavy isotopically labeled
lysine (CNLM-291-H, Cambridge Isotope Laboratories, Inc) and heavy isotopically
labeled arginine (CNLM-539-H, Cambridge Isotope Laboratories, Inc). Unlabeled
Light SILAC media was prepared with 0.1 mg mL−1 L-arginine (A8094, Sigma) and
L-lysine (L8662, Sigma). FBS was extensively dialyzed with PBS using Amicon 3K
MWCO units (Millipore, UK). Viability of hMSC seeded on tissue culture plastic
(TCP) or encapsulated within hydrogels was evaluated using SILAC and control
culture media as described in the Supplementary Methods (Supplementary Fig. 20).
Cell-laden hydrogel preparation for proteomic analysis. hMSC were extensively
washed with PBS and then trypsinized. Trypsin was neutralized with appropriate
SILAC αMEM, no nucleosides, no lipoic acid supplemented with 10% dialyzed
FBS. Some cell suspensions were extensively washed with Heavy SILAC αMEM
(without serum). Cell-laden hydrogels (100 μL, n= 3) were then prepared and
cultured for 72 h under standard conditions with Heavy SILAC supplemented with
10% dialyzed FBS and 1% antibiotic-antimycotic solution. To generate time-course
data, cell suspensions were treated identically with the exception that cells were
washed and cultured with Light SILAC medium. After 24 or 48 h, Light SILAC
medium was replaced by heavy SILAC medium and hydrogels cultured for 72 h in
total. Samples were decellularized with 0.5% Triton X-100 in PBS supplemented
with 20 mM ammonium hydroxide (both Sigma) by gentle agitation for 90 min at
RT52. Samples were then extensively washed with PBS and stored in PBS supple-
mented with 1% antibiotic-antimycotic solution at 4 °C. The efficiency of hydrogel
Fig. 4 Y-27632 and paclitaxel impact osteogenic/adipogenic gene expression. a Gene expression analyses for markers of adipogenesis (PPARγ and C/
EPBα) and osteogenesis (RUNX2 and BGLAP) in hMSC cultured for 72 h with basal culture medium (−Y) or treated with 10 μM Y-27632 (+Y, n≥ 8).
Expression levels (mean+ s.d.) are shown as fold change normalized to expression in undifferentiated hMSC (set to 1). b Representative micrograph of
hMSC (5 × 106 cells mL−1) encapsulated in a 1:0.75 hydrogel after 28 days showing fibronectin, α5 integrin, and DAPI. Fibronectin co-localized with
punctate α5 integrin by Manders’ coefficients: Manders’ tM1= 0.83 ± 0.18 and Manders’ tM2= 0.84 ± 0.10 (n= 4, 25 cells). c Representative micrographs
of hMSC within hydrogels after 72 h and stained with Phalloidin-TRITC (actin) and DAPI. d Gene expression analyses for markers of adipogenesis (PPARγ
and C/EPBα) and osteogenesis (RUNX2 and BGLAP) in hMSC cultured for 72 h with basal culture medium (−PTX) or treated with 50 nM paclitaxel (+PTX,
n≥ 8). Expression levels (mean+ s.d.) are shown as fold change normalized to expression in undifferentiated hMSC (set to 1). e Representative
micrographs of hMSC (5 × 106 cells mL−1) within a 1:0.75 hydrogel for 72 h and stained for tubulin and DAPI. Scale bars in b, c, and e are 100 µm, and in
insets= 10 µm. In a and d a Mann–Whitney test (two-tailed) was used to detect statistical significance, *p < 0.05, **p < 0.01, ***p < 0.001
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decellularization was confirmed by fluorescence microscopy by staining with 1 μg
mL−1 4′,6-diamidino-2-phenylindole (DAPI, #D3571, Molecular Probes), and
1:100 Phalloidin-Tetramethylrhodamine B isothiocyanate (TRITC)53 from Ama-
nita phalloides (#P1951, Sigma).
In-hydrogel digestion for proteomic analysis. Each hydrogel was incubated for
10 min at RT with 100 µL acetonitrile (Optima, LC/MS Grade, Fisher Chemical),
which caused them to shrink and whiten in colour. Each hydrogel was then
transferred to a 2 mL tube and the acetonitrile was removed. Lyophilized trypsin
(Sequencing Grade Modified Trypsin, Promega) was made up to 100 ng µL−1 in 50
mM acetic acid, then diluted ten-fold in 100 mM ammonium bicarbonate to give a
10 ng µL−1 working solution. 50 ng trypsin was added to the hydrogel and allowed
to absorb into the hydrogel for 30 min at RT. 100 µL 100 mM ammonium bicar-
bonate was then added and the hydrogel was incubated overnight at 37 °C on a
bench top mixer set to mix at 800 rpm. The tube was centrifuged (425 rcf, 3 min,
25 °C) and the supernatant (containing peptides) was transferred to a new 2mL
tube. 30 µL acetonitrile was added to the hydrogel and incubated for 5 min at RT.
The tube was then centrifuged (425 rcf, 3 min, 25 °C) again and the supernatant
was combined with the previous supernatant creating the final peptide sample. The
sample was vacuum centrifuged to dryness for 30 min then a C18 reversed phase
clean-up was performed using in-house prepared StageTips54. Peptides were finally
eluted from the StageTip with 80% acetonitrile/5% trifluoroacetic acid (TFA) and
vacuum centrifuged to dryness.
Mass spectrometry (MS) analysis. Dried peptides were re-suspended in 15 µL
0.1% TFA, sonicated for 10 min and centrifuged (20,817 rcf, 3 min, 25 °C). 5 µL of
supernatant was transferred to a glass autosampler vial containing 45 µL of 0.1%
TFA to give a 1:10 dilution. This was determined as an appropriate concentration
based on preliminary experiments. 10 µL sample was analyzed in technical dupli-
cate using a ThermoFisher Scientific QExactive mass spectrometer coupled to an
UltiMate 3000 HPLC system for on-line liquid chromatographic separation. The
sample was initially loaded onto a C18 trap column (ThermoFisher Scientific
Acclaim PepMap 100; 5 mm length, 300 µm inner diameter) then transferred onto
a C18 reversed phase column (ThermoFisher Scientific Acclaim PepMap 100; 50
cm length, 75 µm inner diameter). Peptides were eluted with a linear gradient of
5–40% buffer B (80% acetonitrile, 0.1% formic acid, 5% DMSO) at a flow rate of
250 nL min−1 over 35 min.
Higher energy collisional dissociation was selected as the activation method.
Singly-charged and unknown charge state precursor ions were not analyzed. Full
MS spectra were acquired in the orbitrap (m/z 300–1800; resolution 70k; AGC
target value 1E6) with the MS/MS spectra of the ten most abundant precursors
from the preceding MS survey scan then acquired (resolution 17.5k, AGC target
value 1E5; normalized collision energy 28 eV; minimum AGC target 1E2). Selected
precursors were dynamically excluded for 15 s.
Proteomic data analysis. Acquired raw data were analyzed with MaxQuant
software (version 1.3.0.5)55. MaxQuant was set up to analyze SILAC samples by
selecting a multiplicity of 2 and heavy labels Arg10 and Lys8. MS/MS spectra were
searched against a UniProtKB human protein database (downloaded May 2017;
159,743 entries) using the Andromeda search engine. Common protein con-
taminants were included in the search. Trypsin enzyme was selected (C-terminal
cleavage of arginine and lysine residues) and a maximum of two missed cleavages
was permitted. Carbamidomethylation of cysteine was set as a fixed modification;
N-terminal protein acetylation and methionine oxidation were set as variable
modifications. All other MaxQuant parameters were maintained at default
including a peptide false discovery rate of 0.01.
The resulting protein Groups.txt file was opened in Microsoft Office Excel 2016.
Percentage heavy label incorporation values were created for each protein using the
formula “(R/(1+ R)) × 100%”, where R is the ratio of the heavy and light peptide
signal as calculated by MaxQuant. The file was saved as a txt file and then opened
in Perseus (version 1.4.0.2)56. For each sample, a minimum ratio H/L count
threshold of 3 for both technical duplicates was set. The ratio H/L count refers to
the number of peptide quantification events used for protein quantification.
Technical replicates were plotted using the scatterplot function. Gene ontology
annotation was performed to identify ECM proteins.
Visualization of protein production. Cell-laden hydrogels (n= 3) were prepared
as described above in high glucose DMEM without glutamine, methionine, or
cystine (#21013024, Life Technologies) supplemented with 4 mM L-glutamine,
0.201 mM L-cystine (#C7602), 1 mM sodium pyruvate, 50 μg mL−1 ascorbate 2-
phosphate, and 40 μg mL−1 proline (all form Sigma). Cell-laden hydrogels were
cultured for 72 h in medium supplemented with 1.25 mgmL−1 bovine serum
albumin (Sigma), 0.1% insulin-transferrin-selenium (Thermo Fisher Scientific), 1%
(v/v) antibiotic-antimycotic solution and with either 0.1 mM L-methionine
(#M5308, Sigma; control media) or 0.1 mM L-homopropargylglycine (HPG,
#C10186, Molecular Probes; labeling media). HPG was then identified using a
click-IT HPG Alexa Fluor 488 protein synthesis assay kit (#C10428, Molecular
Probes), following the manufacturer’s instructions at RT. Briefly, samples were
fixed in 4% (w/v) paraformaldehyde (PFA) in PBS for 20 min, rinsed twice with
PBS, and incubated for 1 h with the labeling solution. Samples were then washed
for 5 min in reaction rinse buffer, and then once with PBS. Nuclei were labeled with
NuclearMaskTM in PBS for 15 min, and samples were washed thrice with PBS
before imaging. Controls were treated similarly to labeled samples except the
labeling media was replaced with control media, which did not contain HPG
(Supplementary Fig. 21). Samples were coverslipped using PBS and imaged as
intact hydrogels on a Leica DM16000 confocal laser scanning microscope (Leica
Microsystems, CH). Detector gains were set to be constant between samples to
facilitate comparison. Differential interference contrast (DIC) imaging was used to
delineate the cell membrane. Z-series with 2 µm Z-spacing were obtained in ran-
domly selected fields using sequential acquisition and Kalman filter mode with a
×40 oil objective with a numerical aperture of 1.25, and 2048 × 2048 pixel size.
Images show 3D projections obtained using the Nikon’s NIS-Elements AR
4.51.00 software and insets correspond to max projections of 5 central Z-slices of
2 μm obtained using Image J. Only in cells which we were able to capture the entire
cell and its secreted pericellular matrix, 2 central Z-slices were selected, and 20
random lines were generated by drawing radii extending from the cell membrane
(cell membrane identified by DIC, scheme and example analyses are shown in
Supplementary Fig. 21). The fluorescence intensity of the labeled secreted protein
as function of distance from the cell membrane was then measured in radial profile
plots using the Image J plugin Multi plot. Each value of intensity (arbitrary units)
corresponds to a single pixel at the indicated distance from the cell membrane. A
total of 40 measurements were performed per cell, and 30 cells were analyzed per
condition (total of 1200 plots of intensity vs. distance from the cell membrane).
Values reported are the mean ± s.e.m. The effect of the hyaluronidase inhibitor
Vcpal (100 μM) on hMSC protein secretion was determined identically, but cell-
laden hydrogels (n= 3) were treated with the inhibitor (Vcpal+) for 72 h prior to
analysis.
Gene expression analyses of hMSC within hydrogels. Hydrogels were snap
frozen in liquid nitrogen, stored at −80 °C, and then homogenized in Lysing
Matrix H tubes (MP Biomedicals, USA) on a FastPrep®−24 (MP Biomedicals, 4.5
m s−1 for 2 cycles of 10 s). RNA was isolated using an RNeasy Mini Kit according
to the manufacturer’s instructions using QIAshredder and the RNase-Free DNase
Set (all from Qiagen, NL). RNA was eluted in 30 μL of UltraPure™ DEPC-Treated
Water (Invitrogen) and reverse transcribed into cDNA in two steps. First 10 μL of
RNA, 2 μL 500 μg mL−1 random primers (Promega), and 2 μL of RNase-free water
were incubated at 70 °C for 5 min. Next, the reaction mixture was mixed with 1.25
μL 1mM PCR Nucleotide Mix (Promega), 5 μL M-MLV reverse transcriptase 5×
buffer, 1 μL M-MLV 200 U μL−1 reverse transcriptase (Promega), and 3.75 μL
RNase free water and incubated for 1 h at 42 °C. cDNA was stored at −20 °C.
Quantitative polymerase chain reaction (qPCR) was performed on a Bio-Rad
CFX384 TouchTM real-time PCR detection system using 384-Well PCR Plates (all
from Bio-Rad Laboratories Ltd., UK). Reaction mixtures were prepared with 5 μL
2× Brilliant III SYBR Green qPCR Master Mix (Agilent, USA), 3 μL of primer mix
(forward and reverse), 1.5 μL RNase-free water and 0.5 μL of cDNA. A three-step
cycle was employed: (1) denaturation at 95 °C for 3 min; (2) annealing/extension at
58 °C for 10 s; and (3) melting from 65 °C to 95 °C at 0.5 °C per step for 5 s.
Reference genes (RG) were chosen after testing their stability over time in
hMSC encapsulated in hydrogels as RG stability is known to vary when cells are
combined with materials57, or in 2D vs. 3D culture58. Briefly, serial dilutions of
samples pooled from different conditions (time in culture, PEGDA concentration,
and cell density) were ranked according to repeatability of the gene expression
differences. Geometric means calculated in RefFinder which combines
Comparative ΔCT58, BestKeeper59, Normfinder60, and geNorm61 indicated the
most stable RG (Supplementary Table 4). Primers (Integrated DNA Technologies,
UK) were designed with Primerbank57 and Primer Blast (Supplementary Table 5).
Samples (n ≥ 4) were run in triplicate and water was used in place of cDNA as a
control. The ΔΔCT method62 was used to quantify fold changes in the expression
for each gene of interest (GOI) and normalized to the expression of
undifferentiated hMSC (day 0), using RPL13a and EEF1A1 as the RG: fold change
in expression= 2−ΔΔCq, ΔΔCq= [(CqGOI,t(x) –CqRG,t(x)) – (CqGOI,t(0) –CqRG,t(0))].
Ratio of expression of PPARγ to RUNX2 was calculated using the fold change in
expression of PPARγ normalized to the average fold change in expression of
RUNX2. Data shown are means+ s.d. of the biological replicates.
Assessing hMSC terminal differentiation in hydrogels. Cell-laden hydrogels
(5 × 105 cells mL−1, n= 3) were incubated for 14 days in co-induction medium
(adipogenic/osteogenic co-inductive medium mixed in a 1:1 ratio) that was
exchanged every 3–4 days. Adipogenic inductive medium was prepared with
αMEM supplemented with 10 % (v/v) FBS, 1% (v/v) antibiotic-antimycotic solu-
tion, 1 μM dexamethasone, 0.2 mM indometacin, 10 μg ml−1 insulin, 0.5 mM 3-
isobutyl-1-methilxantin and 3.5 g mL−1 glucose (all from Sigma). Osteogenic
medium was prepared with αMEM supplemented with 10 % (v/v) FBS, 1% (v/v)
antibiotic-antimycotic solution, 0.2 mM ascorbic acid, 10 mM β-glycerophosphate,
10 nM dexamethasone and 3.5 g mL−1 glucose (all from Sigma). Additional cell-
laden hydrogels (n= 3) were also treated with Exo-1 (75 μM) or Vcpal (100 μM)
for 14 days in co-induction medium.
After culture, hydrogels were fixed in 4% (v/v) PFA in PBS for 20 min. After
washing in PBS, samples were treated with 0.1% (v/v) Triton-X-100 and 0.1% (v/v)
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Tween-20 for 30 min at RT. Alkaline phosphatase (ALP) activity and neutral lipid
accumulation were visualized by ALP and Oil Red O (ORO) staining35,
respectively, on whole mounted hydrogels. For ALP staining, samples were
equilibrated in alkaline staining buffer (100 mM CaCl2, 100 mM Tris-HCl, 100 mM
NaCl, 0.1% (v/v) Tween-20, 50 mM MgCl2, pH 8.2) for 20 min, and then incubated
for 3 h at RT in the same buffer with the addition of 500 μg mL−1 naphthol and
500 μg mL−1 Fast Blue BB (all from Sigma). For ORO staining, samples were
equilibrated for 20 min in PBS with 100 mM CaCl2 and 0.1% Tween-20 and then
stained for 2 h at RT with a solution of 600 μg mL−1 ORO in isopropyl alcohol (all
from Sigma), both as previously described4. After two washes in the buffers
mentioned above and two washes in PBS, nuclei were counterstained with 1 μgmL−1
DAPI for 30 min at RT. Samples were washed thrice with PBS, fixed a second time
in 4% PFA with 100 mM CaCl2 and 0.1% (v/v) Tween-20, washed, and mounted in
PBS. Color and fluorescence micrographs were acquired in randomly selected fields
using an Axiovert 200M Zeiss microscope and a QImaging Retiga R3 CCD camera
using a ×20 objective. The fraction of hMSC stained with ALP or ORO were
counted using DAPI counterstaining in more than 20 imaged fields per condition.
In total, between 300–1200 cells were analyzed per condition.
Inhibiting hyaluronidase activity and protein secretion. To determine appro-
priate inhibitors and doses that would either disrupt protein secretion or inhibit
hyaluronidase activity, the following compounds were tested: L-ascorbyl palmitate
(Vcpal; 10 mM stock solution in DMSO, Sigma) is a well-studied inhibitor of
hyaluronidase activity;32 Golgicide A (35 mM stock solution in DMSO, Sigma)
inhibits Golgi BFA resistance factor 1 (GBF1) function63, arresting secretion of
soluble and membrane associated proteins; Brefeldin A (35 mM stock solution in
DMSO, Sigma) disrupts protein translocation to the Golgi64,65; and Exo-1 (2-(4-
Fluorobenzoylamino)-benzoic acid methyl ester, 35 mM stock solution in DMSO,
Sigma) perturbs exocytosis as it modifies Golgi ARF1 GTPase activity and thus
trafficking between the ER and Golgi30. Serial dilutions of all inhibitors were used
to test hMSC viability on TCP and in 3D (Supplementary Methods). Inhibition of
protein secretion was evaluated by immunostaining for fibronectin (Supplementary
Methods, Supplementary Fig. 22 and Supplementary Table 6). The ability of Vcpal
to inhibit hyaluronidase activity was evaluated as previously described66. Briefly, a
10 mM Vcpal stock solution was prepared in DMSO; hyaluronidase was prepared
in PBS at 200 U mL−1 and both syringe filtered (0.22 µm). An enzyme/inhibitor
solution was then prepared with 100 µM Vcpal per 100 U mL−1 hyluronidase and
incubated for 1 h at 37 °C while shaking. The solution was centrifuged, and the
supernatant retained. 2 mgmL−1 of S-HA and the enzyme/inhibitor supernatant
were then mixed 1:1 and incubated at 37 °C while shaking for up to 48 h. Samples
were loaded on 10% polyacrylamide gels for size separation (using PageRuler Plus
Prestained Protein Ladder, 10 to 250 kDa, ThermoFisher) and images captured
after staining with 0.005% Stains-All (E9379, Sigma) in a 50% ethanol/dH2O
solution overnight at RT and destaining with 10% ethanol/dH2O. Exo-1 (75 μM)
and Vcpal (100 μM) in basal culture medium were added 2 h after cell-laden
hydrogels were formed. After 3 days under standard culture conditions, viability,
gene expression analysis, and AFM measurements were performed.
Blocking cell-ECM interactions. To block cell-ECM interactions, hMSC were pre-
incubated for 45 min at 4 °C before encapsulation within hydrogels in basal culture
medium (vehicle) or with 10 μg mL−1 mouse anti-CD44/H-CAM monoclonal
IgG1 antibody [5F12] (#MA5-12394, Invitrogen, Thermo Fisher Scientific), or
mouse IgG1, κ isotype control (#MA5-14453, Invitrogen, Thermo Fisher Scientific)
both concentrated after 3 washes with PBS to remove sodium azide using Amicon
30 K MWCO units (Millipore, UK)67,68, or 300 μg mL−1 of RGD+ (Gly-Arg-Gly-
Asp-Ser-Pro, GRGDSP, Bachem, CH), or 300 μg mL−1 RGD- (Gly-Arg-Ala-Asp-
Ser-Pro, GRADSP, Bachem)69,70 peptides (n ≥ 5). After encapsulation, media
containing the antibody or peptides (at the same concentrations) were added to
appropriate wells. Data for viability and gene expression are presented as means+
s.d. of the biological replicates.
Inhibition of RhoA/ROCK and microtubule depolymerization. To block Rho-
associated, coiled-coil containing protein kinase (ROCK) activity, hMSC-laden
hydrogels (n ≥ 5) were cultured in basal medium (vehicle) or treated with 10 μM Y-
27632 (Y, [(1)-(R)-trans-4-(1-aminoethyl)-N-(4-pyridyl)cyclohexanecarboxamide
dihydrochloride], Merck) for 72 h. To inhibit microtubule disassembly, hMSC-
laden hydrogels (n ≥ 5) were treated with 50 nM paclitaxel (PTX, #ab120143,
Abcam) for 72 h. Vehicle controls were cultured in basal culture medium. Data for
viability and gene expression are presented as means+ s.d. of the biological
replicates.
Statistical analyses. For all in vitro experiments, samples were prepared, treated,
processed and analyzed in random order. No statistical method was used to pre-
determine sample size, and experiments were performed without blinding. Mea-
surements of E (after removal of outliers with ROUT test Q= 1%) are shown as
histograms (percentage) and box plots expressing the median (central line), first
and third quartiles (bounds of box), and the highest and lowest values (whiskers).
Flow cytometry results are shown as medians with s.e.m. All other results are
shown as means and s.d. or s.e.m. Statistical analyses were carried out using a non-
parametric Kruskal–Wallis test followed by Dunn’s multiple comparison test for
multiple comparisons or a Mann–Whitney test (two-tailed) for comparisons
between two groups. Statistical analyses for ORO or ALP quantification were
performed by Fisher’s exact test (two-sided). Significant differences in the dis-
tributions of stiffness values between acellular and cell-laden hydrogels, or treated
with Exo-1 or Vcpal were evaluated using a Mantel–Haenszel linear-by-linear
association chi-squared (χ2) test for trend. Power was evaluated by determining
Goodman and Kruskal’s gamma (γ) and standardized residuals were used to
identify the most significant intervals that contributed to differences between
histograms, all three using IBM® SPSS® statistics version V23. All other statistical
analyses were carried out using GraphPad Prism version 7 for Windows (Graph-
Pad Software, USA). p values are indicated in figure captions or can be found in
Supplementary Tables 2 and 3.
Data availability
The full mass spectrometry proteomics data obtained in this study have been deposited
with the ProteomeXchange Consortium via the PRIDE partner repository with the
dataset identifier PXD009500. The authors declare that all data supporting the findings of
this study are available within the article and its supplementary information files or from
the corresponding author upon reasonable request.
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